Adcock Ingram Integrated Report 2018

27 ADCOCK INGRAM  Integrated Report 2018 u u National Renal Care (a Netcare and AICC joint venture) remains the single largest service provider for renal services in South Africa. u u AICC is the largest supplier of goods and services within: − − Peritoneal Dialysis (PD); − − Haemodialysis (HD); − − Continuous Renal replacement Therapy (CRRT); and − − Renal Pharmaceuticals. u u The largest supplier of large volume parenterals (LVP’s) within Southern Africa. u u Continues to grow its share of the small volume parenteral (SVP’s) market through various commercial strategies. u u The market leader in regional anaesthesia. u u Through its strategic alliance with Pharma-Q, AICC has a solid market leadership position in SVP’s (injectable pharmaceuticals) across multiple therapeutic areas including anti-infectives, oncology, anti-emetics, respiratory, analgesia and hypnotics. u u Largest supplier of blood bags in South Africa and is the largest supplier to SANBS (South African National Blood Services) with whom it has enjoyed a relationship of more than 50 years. u u Enjoys manufacturing independence and benefits from a fully integrated manufacturing facility supporting the local manufacture of blood bags and tubing. u u Largest supplier of free-flowing leucodepletion sets. u u Through its alliance with Applied Sciences in the USA, AICC has successfully installed the largest fleet of combination blood mixers and scales in South Africa. u u A leader in the supply of: − − products for Haemophilia − − speciality pharmaceuticals including sodium polystyrene, heparin and 1 alpha hydroxylase. BUSINESS FOCUS u u Continue to concentrate its efforts on nurturing focussed portfolios with key attention on product mix, processes and people. u u Uncompromising attention to customer service in supply, delivery, service and communications. u u Maintain and grow its market leading position in both established as well as newly penetrated therapy areas. u u Expand into adjacent categories through licensing, partnerships and strategic alliances. u u Key focus on operations with emphasis on yield, reducing waste, efficiencies and automation. u u Maintain a close relationship with government and support national communities in providing quality healthcare products affordable to all. u u Maintain close relationships with all stakeholders to build trust, demonstrate commitment and deliver to expectation. Renal Medicine Delivery Transfusion therapies Specialised Pharmaceuticals ACHIEVEMENTS IN 2018 AICC has progressed several innovations through the 2018 financial year which support growth ambitions in its base business, and aspirations in adjacent categories as it looks to expand its portfolio. These include: u u Kinesiology – obtained licensing rights for a leading kinesiology tape “SpiderTech TM ”. This positions AICC in the ‘home critical care’space where it will seek to bolt on product extensions. u u Disinfectants – AICC has launched its own range of hand and surface disinfectants. Housed under the Adco-Hygiene brand, AICC has made available several unique formulations which vary in size, fragrance, texture and colour. The range is accredited with standards authorities, such as NRCS (National Regulator for Compulsory Specifications), and has anti-bacterial, anti-viral and anti-fungal properties. The products are intended for home and professional use. u u In the Renal business, 2018 has seen the introduction of an innovative new cycler for PD which allows healthcare professionals to monitor dialysis patients remotely via a mobile app. OVERVIEW Adcock Ingram Critical Care (AICC) is a leading manufacturer and supplier of hospital and critical care products in Southern Africa. Products are offered through multiple portfolios and across wide-ranging customer channels. The business is a fully integrated operation which spans regulatory, manufacturing, marketing, sales and distribution. Beyond its world-class commercial capability, AICC manufactures an extensive range of products in its unique dual-process factory which comprises a comprehensive plastics extrusion plant together with a fully accredited pharmaceuticals manufacturing facility. AICC is a progressive healthcare company with ever-evolving and broadening portfolios. At the core, AICC holds a solid market leadership position in intravenous solutions, renal therapies and blood transfusion therapies where it is the largest supplier of blood donation bags to the South African National Blood Services. Other product portfolios include small volume injectables, infusion systems, invasive diagnostics, nutrition, and specialised pharmaceuticals. In its efforts to maintain its leadership position, AICC continues to expand into newer novel portfolios which include growth in opioid substitution therapy, oral and injectable analgesia, additional injectable pharmaceuticals, immunosuppressants, hand and surface disinfectants and kinesiology tapes.